BioCentury
ARTICLE | Company News

Pikamab, University of Alabama at Birmingham Research Foundation deal

July 5, 2010 7:00 AM UTC

Pikamab received exclusive rights to the foundation's U.S. Patent No. 6,986,987, which covers the role of the functional polymorphism (Ser/Gly-248) in the cytoplasmic domain of CD89 (Fc alpha recepto...